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Background
Due to the increasing social, medical and occupational
exposure to Cannabis sativa, allergic reactions grow in
frequency but little is known about the IgE-reactivity of
single Cannabis allergens.
Methods
To identify the mature peptide sequence of the lipid
transfer protein (LTP) and to study the IgE-binding
reactivity of a recombinant Can s 3 (rCan s 3), a cDNA
was synthesized from total RNA of Cannabis sativa L.
ssp. sativa cv. Kompolti leaves obtained from the botanical
garden of the University Bonn. The LTP gene was
amplified with a primer mix deduced from published
amino acid sequences. The LTP variant was identified in
five independent clones by sequencing in the pDrive
vector system followed by the expression of the mature
LTP in the pMAL-vector. After isolation of a soluble
recombinant maltose-binding protein (MBP)-Can s 3
fusion protein, aliquots were biotinylated and coupled to
Streptavidin-ImmunoCAPs.
Results
Sera of 16 (6 Spanish and 10 German) subjects with
allergic symptoms to Cannabis were tested. Specific IgE
(sIgE) values >0.35 kUA/L were regarded as positive.
Twelve out of 16 sera (75%) showed sIgE to Cannabis
(range: 0.42-31.80 kUA/L). Five of them (31%) displayed
sIgE to rCan s 3 (range: 0.40-14.10 kUA/L) but no sIgE
to MBP. Specific IgE-reactivity to Pru p 3 was detected
in all Cannabis-positive sera from Spain but only in 3
out of 6 German sera. All sera with sIgE to rCan s 3
showed also sIgE to Pru p 3.
Conclusions
These results show for the first time IgE-binding of a
recombinant Cannabis allergen (rCan s 3). Due to the
60% amino acid identity between Can s 3 and Pru p 3 a
cross-reactivity is possible, but also to the LTPs of other
plants. Since rCan s 3 is now available for sIgE diagnostics,
implementation in larger studies may help to further
elucidate the impact of this allergen.
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